Feature Channels: Kidney Disease

Filters close
Newswise: sabygeorgenewweb.jpg
Released: 15-Sep-2024 11:05 AM EDT
Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer
Roswell Park Comprehensive Cancer Center

During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.

Newswise: Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Released: 13-Sep-2024 10:05 AM EDT
Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Dana-Farber Cancer Institute

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.

access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 12:00 PM EDT Released to reporters: 12-Sep-2024 4:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
9-Sep-2024 8:05 AM EDT
Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
Dana-Farber Cancer Institute

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.

Newswise: Urate Transporter Structures Reveal the Mechanism Behind Important Drug Target for Gout
Released: 9-Sep-2024 11:05 AM EDT
Urate Transporter Structures Reveal the Mechanism Behind Important Drug Target for Gout
St. Jude Children's Research Hospital

Ten structures of URAT1 obtained by scientists at St. Jude Children’s Research Hospital provide a deep understanding of the mechanism of urate transport to guide gout therapeutic design.

Newswise: One of the First of Its Kind, Uah Study Characterizes Urinary Microbes in Children
Released: 6-Sep-2024 3:05 PM EDT
One of the First of Its Kind, Uah Study Characterizes Urinary Microbes in Children
University of Alabama Huntsville

Until recently, it was believed that human urine is sterile, but advanced culturing techniques and DNA sequencing have revealed that bacteria and other microbes – such as viruses and fungi – inhabit the human bladder and urinary tract, known collectively as the “urobiome.” Now in study that is one of the first of its kind, Dr.

Newswise: Widespread disparities exist in treating advanced cancers
Released: 4-Sep-2024 11:05 AM EDT
Widespread disparities exist in treating advanced cancers
UT Southwestern Medical Center

A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers.

Released: 28-Aug-2024 7:00 AM EDT
Presión arterial alta daña los riñones
Mayo Clinic

La hipertensión, también conocida como presión arterial alta, es un problema común que afecta las arterias del cuerpo. Si tiene presión arterial alta, el corazón tiene que trabajar más para bombear la sangre.

Released: 21-Aug-2024 1:05 PM EDT
Two Women from the Same Church Receive Organ Transplants Three Days Apart
Loyola Medicine

Two women who attend the same church and have been praying for one another to find a match, recently received transplants at Loyola University Medical Center just three days apart.

Not for public release

This news release is embargoed until 19-Aug-2024 5:00 PM EDT Released to reporters: 13-Aug-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Aug-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Children’s Research Institute at UT Southwestern scientists discover kidney cancers rely on mitochondrial metabolism to metastasize
Released: 14-Aug-2024 12:05 PM EDT
Children’s Research Institute at UT Southwestern scientists discover kidney cancers rely on mitochondrial metabolism to metastasize
UT Southwestern Medical Center

Contrary to how tumors operate while still in the kidney, metastatic kidney cancers rely heavily on mitochondrial metabolism, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Nature.

Released: 14-Aug-2024 9:05 AM EDT
Study by Cleveland Clinic, Tufts University Highlights Potential for Using TMAO -- a Digestive By-Product -- to Predict Heart Failure Risk
Cleveland Clinic

New Cleveland Clinic and Tufts University research shows that elevated levels of the gut microbiome trimethylamine N-oxide (TMAO) pathway led to a higher risk of heart failure independent of other risk factors, according to a study of two large National Institutes of Health cohorts. The study was recently published in the journal Circulation: Heart Failure.

Released: 12-Aug-2024 10:05 AM EDT
Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research
Beth Israel Lahey Health

Rohit N. Kulkarni, MD, PhD, the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at Joslin Diabetes Center, has been awarded $9,920,607 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).

Released: 8-Aug-2024 5:05 PM EDT
Study shows donor kidneys with toxoplasma do not increase risks for transplant patients
UC Davis Health

Researchers determined that transplant patients who receive kidneys infected with the parasite toxoplasma have virtually the same outcomes as those who receive toxoplasma-negative organs.

Newswise: Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes
Released: 26-Jul-2024 3:05 PM EDT
Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes
University of California, Los Angeles (UCLA), Health Sciences

A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.

Newswise: SLU Researchers Invite Living Kidney Donors and Recipients to Join NIH-funded Study to Overcome Disparities in Kidney Disease, Transplantation
Released: 17-Jul-2024 1:05 PM EDT
SLU Researchers Invite Living Kidney Donors and Recipients to Join NIH-funded Study to Overcome Disparities in Kidney Disease, Transplantation
Saint Louis University

Saint Louis University School of Medicine researchers led by Krista Lentine, M.D., Ph.D., professor of medicine, will assess how the use of genetic testing may mitigate racial disparities in the health outcomes of people with chronic kidney disease, including organ donors and transplant recipients.

Newswise: Cancer researchers receive grant to combat aggressive kidney cancer
Released: 16-Jul-2024 11:05 AM EDT
Cancer researchers receive grant to combat aggressive kidney cancer
University of California, Los Angeles (UCLA), Health Sciences

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center(Link opens in new window) have received an $800,000 grant from the V Foundation to find new ways to treat and prevent a severe form of kidney cancer associated with a hereditary syndrome caused by mutations in the fumarate hydratase (FH) gene.

Newswise: George Bakris, internationally recognized hypertension expert, 1952-2024
Released: 11-Jul-2024 5:05 PM EDT
George Bakris, internationally recognized hypertension expert, 1952-2024
University of Chicago Medical Center

Bakris served on the UChicago faculty for 18 years and was director of the Comprehensive Hypertension Center.

Newswise: Take summer heat health risks seriously, UTSW experts caution
Released: 5-Jul-2024 2:05 PM EDT
Take summer heat health risks seriously, UTSW experts caution
UT Southwestern Medical Center

The scorching heat can be inescapable this time of year, and as temperatures hover around triple digits, experts at UT Southwestern Medical Center caution that uncomfortable weather can escalate to dangerous health conditions.



close
2.24078